Clinical Trial Update: Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating autologous adipose tissue stromal vascular fraction cells for rheumatoid arthritis has been withdrawn (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Autologous adipose tissue stromal vascular fraction cells

Snippet

Sponsor: Translational Biosciences | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: WITHDRAWN